Skip to main content

Table 2 summary description of the tool development process and risk of bias

From: Prognostic models for intracerebral hemorrhage: systematic review and meta-analysis

Author

Source of data

Sampling reported

Nr patients

Nr events

Nr variable

EPV

Loss to follow-up:

Missing data reported?

Blinding reported?

Modelling method

Internal validation

Calibration

Alsina [24]

Cohort

Not reported

100

38

3

12.7

0%

Yes

No

Logistic

No

Hosmer-Lemeshow

Berwaerts [41]

Cohort

Consecutive

42

18

2

9

0%

Yes

No

Logistic

No

Not reported

Bhatia [65]

Cohort

Consecutive

214

70

4

17.5

0%

No

No

Logistic

No

Not reported

Broderick [44]

Cohort

Consecutive

162

83

2

19.8

0.6%

Yes

No

Logistic

No

Not reported

Broderick´ [44]

Cohort

Consecutive

162

83

4

39.5

0.6%

Yes

No

Logistic

No

Not reported

Celik [68]

Cohort

Not reported

257

119

12

9.9

0%

No

No

ANN

Cross-validation

Not reported

Cerillo [21]

Cohort

Not reported

88

34

7

4.9

0%

No

No

Univariate analysis

No

Not reported

Chen [45]

Cohort

Consecutive

285

61

4

15.3

0%

No

No

Logistic

No

Not reported

Chiu [61]

Cohort

Not reported

106

16

2

8

0%

Yes

No

CART + SVM

Split sample

Not reported

Chuang [63]

Cohort

Not reported

293

40

5

8

0%

No

No

Logistic

Cross-validation

Hosmer-Lemeshow

Edwards [28]

Cohort

Consecutive

81

21

15

1.4

0%

No

No

ANN

No

Hosmer-Lemeshow

Edwards´ [28]

Cohort

Consecutive

81

21

4

5.3

0%

Yes

No

Logistic

No

Hosmer-Lemeshow

Fogelholm [31]

Cohort

Consecutive

282

120

6

20

0%

Yes

No

Logistic

No

Not reported

Frithz [12]

Cohort

Not reported

91

79

2

6

0%

Yes

No

CART

No

Not reported

Galbois [38]

Cohort

Consecutive

72

35

2

17.5

0%

Yes

No

Logistic

Cross-validation

Not reported

Galbois´ [38]

Cohort

Consecutive

72

35

2

17.5

0%

Yes

No

Logistic

Cross-validation

Not reported

Grellier [66]

Cohort

Not reported

300

Not reported

9

n/a

0%

No

No

Unclear

No

Not reported

Hallevi [34]

Cohort

Consecutive

174

Not reported

2

n/a

0%

Yes

No

Logistic

No

Not reported

Hemphill [48]

Cohort

Consecutive

152

68

5

13.6

0%

Yes

No

Logistic

No

Not reported

Ho [64]

Registry

Consecutive

805

164

6

27.3

0%

No

No

Logistic

No

Le Cessie and Howelingen + plots

Huang [40]

Cohort

Consecutive

107

72

3

11.7

0%

Yes

No

Logistic

No

Not reported

Li [50]

Cohort

Consecutive

227

49

4

12.3

0%

Yes

No

Logistic

No

Not reported

Li´ [49]

Cohort

Consecutive

716

140

4

35

0%

Yes

No

Logistic

No

Not reported

Lukic [33]

Cohort

Consecutive

411

256

5

31

0%

Yes

No

Logistic

No

Hosmer-Lemeshow

Lukic´ [26]

Case-Control

Not reported

200

100

8

12.5

0%

Yes

No

ANN

Split Sample

Not reported

Lukic´´ [26]

Case-Control

Not reported

200

100

2

50

0%

Yes

No

Logistic

No

Not reported

Masé [27]

Cohort

Consecutive

138

38

3

12.7

0%

No

No

Logistic

No

Not reported

Parry-Jones [53]

Cohort

Consecutive

1175

483

4

120.8

1.1%

Yes

No

Logistic

No

Not reported

Peng [54]

Cohort

Not reported

423

62

20

3.1

0%

Yes

No

Random Forrest

Cross-validation

Not reported

Peng´ [54]

Cohort

Not reported

423

62

10

6.2

0%

Yes

No

ANN

Cross-validation

Not reported

Peng´´ [54]

Cohort

Not reported

423

62

10

12.4

0%

Yes

No

SVM

Cross-validation

Not reported

Peng´´´ [54]

Cohort

Not reported

423

62

5

12.4

0%

Yes

No

Logistic

Cross-validation

Not reported

Romano [56]

Cohort

Consecutive

154

63

3

21

0.6%

Yes

No

Logistic

Split sample

Not reported

Ruiz-Sandoval [58]

Cohort

Consecutive

378

174

5

34.8

0%

Yes

No

Logistic

Bootstrap

Hosmer-Lemeshow

Safatli [60]

Cohort

Consecutive

342

86

3

28.7

0%

No

No

Logistic

No

Hosmer-Lemeshow

Szepesi [32]

Cohort

Not reported

125

59

6

9.8

0%

Yes

No

Logistic

No

Hosmer-Lemeshow

Tabak [59]

Administrative data

Consecutive

29,975

6765

17

397.9

0%

Yes

No

Logistic

Bootstrap

Calibration plot

Takahashi [67]

Cohort

Not reported

347

70

3

23.3

0%

No

No

CART

Cross-validation

Not reported

Takahashi´ [67]

Cohort

Not reported

347

70

4

17.5

0%

No

No

Logistic

No

Not reported

Tshikwela [36]

Cohort

Not reported

185

68

3

22.7

0%

No

No

Logistic

No

Not reported

Tshikwela´ [36]

Cohort

Not reported

185

68

3

22.7

0%

No

No

Logistic

No

Not reported

Tuhrim [23]

Cohort

Not reported

129

27

5

5.4

0%

No

No

Logistic

No

Not reported

Tuhrim´ [30]

Registry

Not reported

187

54

5

10.8

2.1%

Yes

No

Logistic

No

Not reported

Tuhrim´´ [29]

Registry

Not reported

73

25

3

8.3

0%

Yes

No

Logistic

No

Not reported

Ziai [35]

Cohort

Consecutive

170

87

4

20.8

0%

Yes

No

Logistic

Cross-validation

Not reported

Zis [39]

Cohort

Consecutive

191

61

5

12.2

0%

No

No

Logistic

No

Hosmer-Lemeshow

Appelboom [10]

Cohort

Consecutive

84

18

5

3.6

Unclear

Yes

Yes

Logistic (Update)

No

Not reported

Creutzfeld [47]

Cohort

Consecutive

424

187

7

26.7

0%

No

No

Logistic

No

Hosmer-Lemeshow

Flemming [18]

Cohort

Consecutive

81

24

2

12

0%

Yes

No

Decision Tree

No

Not reported

Flemming´ [18]

Cohort

Consecutive

81

51

3

10

0%

Yes

No

Decision Tree

No

Not reported

Hallevy [25]

Cohort

Consecutive

184

70

6

11.7

0%

No

No

Logistic

No

Not reported

Ji [51]

Registry

Consecutive

1953

912

7

130.3

12.6%

Yes

Yes

Logistic

Split sample

Hosmer-Lemeshow

Lisk [22]

Cohort

Consecutive

75

35

4

8.8

0%

Yes

No

Logistic

No

Hosmer-Lemeshow

Lisk´ [22]

Cohort

Consecutive

42

9

3

3

0%

Yes

No

Logistic

No

Hosmer-Lemeshow

Neidert [11]

Cohort

Consecutive

67

28

8

3.5

0%

No

No

Univariate analysis

No

Not reported

Misra [15]

Cohort

Not reported

38

Not reported

4

n/a

Unclear

Yes

No

Logistic

No

Not reported

Mittal [52]

Cohort

Consecutive

92

62

5

6

0%

No

Yes

Logistic (update)

No

Not reported

Portenoy [20]

Cohort

Consecutive

112

41

3

13.7

0%

No

No

Logistic

No

Hosmer-Lemeshow

Poungvarin [55]

Cohort

Consecutive

995

402

4

100.5

0%

Yes

No

Logistic

No

Not reported

Rost [57]

Cohort

Consecutive

418

121

5

24.2

13.4%

Yes

No

Logistic

Split sample

Not reported

Shah [17]

Cohort

Not reported

53

29

2

12

0%

No

No

Logistic

No

Not reported

Shaya [19]

Cohort

Consecutive

50

n/a

3

n/a

0%

No

No

Ordered logistic

No

Not reported

Weimar [42]

RCTs

Not reported

564

171

3

57

0%

Yes

No

Logistic (update)

No

Calibration plot

Weimar´ [37]

Cohort

Consecutive

207

78

2

39

20.4%

Yes

Yes

Logistic

No

Not reported

Weimar´´ [43]

Registry

Consecutive

340

89

3

29.7

27%

Yes

Yes

Logistic (update)

No

Not reported

Cheung [46]

Cohort

Consecutive

141

31a

5

6.2a

0.7%

Yes

No

Logistic

No

Not reported

49b

9.8b

Cheung´ [46]

Cohort

Consecutive

141

31a

5

6.2a

0.7%

Yes

No

Logistic (update)

No

Not reported

49b

9.8b

Cho [14]

RCT

Consecutive

226

42a

3

14a

0%

Yes

No

Logistic

No

Not reported

Unclearb

n/ab

Godoy [62]

Cohort

Consecutive

153

53a

5

10.6a

0%

Yes

No

Logistic (update)

No

Not reported

59b

11.8b

Godoy´ [62]

Cohort

Consecutive

153

53a

5

10.6a

0%

Yes

No

Logistic (update)

No

Not reported

59b

11.8b

Lei [13]

Cohort

Consecutive

170

43a

4

10.8a

0%

No

Yes

Logistic

Split sample

Not reported

90b

20b

Stein [16]

Cohort

Consecutive

110

31a

4

7.8a

0%

Yes

No

Logistic

Split sample

Not reported

86b

4.5b

  1. ANN artificial neural networks, CART classification and regression tree, SVM support vector machine
  2. aValues relating to mortality
  3. bValues relating to functional outcome